(Reuters) – UK health regulators may grant emergency use authorization to Moderna Inc’s COVID-19 vaccine as soon as Friday, making it the third vaccine to receive approval in the country, Bloomberg News reported, citing people familiar with the matter.
Vaccine developed by AstraZeneca Plc and the University of Oxford received approval in December followed by Pfizer Inc and BioNTech SE’s shot.
The two-dose Moderna vaccine has already been rolled out in the United States, Canada. Earlier this week, Israel granted authorisation for the shot.
It was about 95% effective at preventing illness in clinical trials that found no serious safety issues.
(Reporting by Mrinalika Roy in Bengaluru; Editing by Maju Samuel)